Has this become a lifestyle company for the CEO and senior management? The new chairman ( appointed by the CEO) seems only interested in retaining the poorly performing management team. Negative return over 5 years, in what should have been the most exciting period ( post FDA approval). Surely it is time for a change. Enough of the lies and false promises.
looking forward to phi/parvismelanotide results Cy 23 as promised
Has this become a lifestyle company for the CEO and senior...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.16 |
Change
0.120(0.85%) |
Mkt cap ! $709.1M | |||
| Open | High | Low | Value | Volume |
| $13.98 | $14.42 | $13.95 | $1.375M | 96.72K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 106 | $14.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.25 | 800 | 1 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |